Orchid Pharma P/E Ratio

Current P/E Ratio
257.17
High Valuation
Very High - High growth expectations or significantly overvalued

Orchid Pharma (ORCHPHARMA) P/E ratio is 257.17 (High), EPS (TTM) ₹4.05, current price ₹988.60 on NSE vs historical average P/E of 23.41 (100.0th percentile) — Very High - High growth expectations or significantly overvalued. Read Orchid Pharma dividend policy for the complete payout history and dividend yield track record.

Current Valuation Metrics

P/E Ratio 257.17
Current Price ₹988.60
EPS (TTM) ₹4.05
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 23.41
Historical Range 13.77 - 33.04
Percentile 100.0%

Sector Context

Sector Average 54.6
Sector Median 31.4
Sector Rank #11 of 194
Sector Percentile 5.7%

Earnings Breakdown (TTM)

TTM EPS ₹10.90
Mar 2026 ₹4.69
Sept 2025 ₹-1.13

ORCHPHARMA P/E Ratio — Valuation Signal & Historical Context

Orchid Pharma P/E 257.17 vs historical average 23.41, range 13.77–33.04 — signal: Overvalued. For live price, revenue and the complete fundamental profile, see ORCHPHARMA stock price BSE.

  • Stock appears overvalued with PE of 257.17, suggesting caution for new investments
  • Current PE is 998.8% above historical average
  • Trading at premium to sector average PE of 54.6

Orchid Pharma P/E Ratio Historical Trend

ORCHPHARMA annual price-to-earnings ratio — 2 years, EPS and year-end price. Current P/E 257.17 vs historical average 23.41. See ORCHPHARMA P/B ratio to compare market price against book value per share.

ORCHPHARMA Historical P/E Ratio — EPS, Year-End Price & Valuation

Orchid Pharma annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2024 33.04 22.07 ₹729.10 NSE High
2023 13.77 26.82 ₹369.40 NSE Low

ORCHPHARMA vs Healthcare Peers — P/E Ratio Comparison

Orchid Pharma P/E 257.17 vs Healthcare average 54.6, median 31.4 — range 2.86–916.67.

Sector Average
54.6
Sector Median
31.4
Lowest P/E
2.86
Highest P/E
916.67
Companies
194
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Murae Organisor MURAE 2.86 ₹41 Low
Phaarmasia PHRMASI 3.61 ₹64 Low
Sunrest Lifescience SUNREST 3.76 ₹30 Low
Sun Pharma Advanced Rese… SPARC 4.76 ₹7,399 Low
Shelter Pharma SHELTER 5.23 ₹47 Low
Dipna Pharmachem DPL 5.39 ₹14 Low
JFL Life Sciences JFLLIFE 5.41 ₹68 Low
Amwill Health Care AMWILL 7.26 ₹83 Low
Zenith Drugs ZENITHDRUG 7.69 ₹84 Low
Galaxy Medicare GML 7.8 ₹27 Low